Financials
Financial year 2026
Dr. X. Elzo Kraemer, Medisch Oncoloog from Oudenaarde, company number BE0740484043, closed financial year 2026 with a result of € 214,450 after tax. For that financial year Dr. X. Elzo Kraemer, Medisch Oncoloog recorded a gross margin of € 319,058 and equity of € 505,086. Compared with financial year 2025, the result moved from € 149,602 to € 214,450. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2026.
€ 505,086
▲ 44% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 214,450
▲ 43% vs 2025
Profit after tax over the fiscal year.
€ 279,487
▲ 1% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 59,952 paid out
28 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
€ 556
▼ 91% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 147
▼ 84% vs 2025
Loans from banks and other lenders, long and short.
€ 2,919
▲ 77% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 32,354
▲ € 29,229 vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 349,297 | € 327,047 | € 222,944 | € 319,058 | ▲ 43% |
| Profit after taxes | € 240,677 | € 249,676 | € 149,602 | € 214,450 | ▲ 43% |
| Equity | € 417,192 | € 266,868 | € 350,589 | € 505,086 | ▲ 44% |
| Total debts | € 393,975 | € 232,170 | € 82,682 | € 108,888 | ▲ 32% |
| Cash | € 397,111 | € 71,912 | € 277,378 | € 279,487 | ▲ 1% |
| Retained profit | € 414,692 | € 264,368 | € 348,089 | € 502,586 | ▲ 44% |
| Dividend | € 400,000 | € 400,000 | € 65,881 | € 59,952 | ▼ 9% |
| Bank debt | € 18,760 | € 7,138 | € 925 | € 147 | ▼ 84% |
| Balance sheet total | € 811,167 | € 499,038 | € 433,271 | € 613,974 | ▲ 42% |
Key figures of Dr. X. Elzo Kraemer, Medisch Oncoloog, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to Dr. X. Elzo Kraemer, Medisch Oncoloog?
What happened at Dr. X. Elzo Kraemer, Medisch Oncoloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 214,450 (▲ 43% vs 2025). Source: NBB ↗
- New establishment in Deinze. KBO
- New establishment in Gent. KBO
- Ximena Elzo Kraemer became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 240,677 profit in 2023 to € 214,450 profit in 2026.
Paid € 322,520 in corporate taxes since 2023.
Best year ever: 2024, with € 249,676 profit.
Paid out € 925,833 in dividends to the owners in total.
Management
Behind Dr. X. Elzo Kraemer, Medisch Oncoloog is Ximena Elzo Kraemer.
Directors
According to the 2026 annual accounts
Ximena Elzo Kraemer
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Reimond Stijnsstraat 9
9700 Oudenaarde
Schutterijstraat 34
9800 Deinze
Active since 26 December 2019
Buitenring-Sint-Denijs 30
9000 Gent
Active since 26 December 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0740.484.043
- VAT number
- BE 0740.484.043
- Registered office
- Reimond Stijnsstraat 9, 9700 Oudenaarde
- Names & denominations
- Dr. X. Elzo Kraemer, Medisch Oncoloog
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 December 2019
- Peppol
- Active · Active since 4 Apr 2026
- Activities · NACE
Activiteiten van medisch specialisten
Speur- en ontwikkelingswerk op biotechnologisch gebied